Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

Group 1 - Assertio (ASRT) is a stock that has gained about 14% year-to-date, outperforming the average gain of 7% in the Medical group [4] - Assertio is ranked 8 in the Zacks Sector Rank, which evaluates 932 companies within the Medical sector [2] - The Zacks Rank for Assertio is 1 (Strong Buy), indicating a positive earnings outlook with a 6.6% increase in the full-year earnings estimate over the past quarter [3] Group 2 - Assertio belongs to the Medical - Drugs industry, which has 141 stocks and is currently ranked 96 in the Zacks Industry Rank, with an average gain of 1.9% year-to-date [5] - Another outperforming stock in the Medical sector is Butterfly Network, Inc. (BFLY), which has returned 15.8% year-to-date and has a Zacks Rank of 2 (Buy) [4][5] - The Medical Info Systems industry, to which Butterfly Network belongs, has 42 stocks and is currently ranked 168, with a year-to-date gain of 2% [6]